171 related articles for article (PubMed ID: 25666803)
1. Hck inhibitors as potential therapeutic agents in cancer and HIV infection.
Musumeci F; Schenone S; Brullo C; Desogus A; Botta L; Tintori C
Curr Med Chem; 2015; 22(13):1540-64. PubMed ID: 25666803
[TBL] [Abstract][Full Text] [Related]
2. Subtle Dynamic Changes Accompany Hck Activation by HIV-1 Nef and are Reversed by an Antiretroviral Kinase Inhibitor.
Wales TE; Hochrein JM; Morgan CR; Emert-Sedlak LA; Smithgall TE; Engen JR
Biochemistry; 2015 Oct; 54(41):6382-91. PubMed ID: 26440750
[TBL] [Abstract][Full Text] [Related]
3. Identification of Hck inhibitors as hits for the development of antileukemia and anti-HIV agents.
Tintori C; Laurenzana I; La Rocca F; Falchi F; Carraro F; Ruiz A; Esté JA; Kissova M; Crespan E; Maga G; Biava M; Brullo C; Schenone S; Botta M
ChemMedChem; 2013 Aug; 8(8):1353-60. PubMed ID: 23813855
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic cell kinase (Hck) isoforms and phagocyte duties - from signaling and actin reorganization to migration and phagocytosis.
Guiet R; Poincloux R; Castandet J; Marois L; Labrousse A; Le Cabec V; Maridonneau-Parini I
Eur J Cell Biol; 2008 Sep; 87(8-9):527-42. PubMed ID: 18538446
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD45RO suppresses human immunodeficiency virus type 1 replication in microglia: role of Hck tyrosine kinase and implications for AIDS dementia.
Kim MO; Suh HS; Si Q; Terman BI; Lee SC
J Virol; 2006 Jan; 80(1):62-72. PubMed ID: 16352531
[TBL] [Abstract][Full Text] [Related]
6. Dys-regulated activation of a Src tyroine kinase Hck at the Golgi disturbs N-glycosylation of a cytokine receptor Fms.
Hassan R; Suzu S; Hiyoshi M; Takahashi-Makise N; Ueno T; Agatsuma T; Akari H; Komano J; Takebe Y; Motoyoshi K; Okada S
J Cell Physiol; 2009 Nov; 221(2):458-68. PubMed ID: 19585521
[TBL] [Abstract][Full Text] [Related]
7. Oligomerization is required for HIV-1 Nef-induced activation of the Src family protein-tyrosine kinase, Hck.
Ye H; Choi HJ; Poe J; Smithgall TE
Biochemistry; 2004 Dec; 43(50):15775-84. PubMed ID: 15595833
[TBL] [Abstract][Full Text] [Related]
8. Selective targeting of the inactive state of hematopoietic cell kinase (Hck) with a stable curcumin derivative.
Chakraborty MP; Bhattacharyya S; Roy S; Bhattacharya I; Das R; Mukherjee A
J Biol Chem; 2021; 296():100449. PubMed ID: 33617879
[TBL] [Abstract][Full Text] [Related]
9. The identification of a small molecule compound that reduces HIV-1 Nef-mediated viral infectivity enhancement.
Chutiwitoonchai N; Hiyoshi M; Mwimanzi P; Ueno T; Adachi A; Ode H; Sato H; Fackler OT; Okada S; Suzu S
PLoS One; 2011; 6(11):e27696. PubMed ID: 22110726
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway.
Roversi FM; Pericole FV; Machado-Neto JA; da Silva Santos Duarte A; Longhini AL; Corrocher FA; Palodetto B; Ferro KP; Rosa RG; Baratti MO; Verjovski-Almeida S; Traina F; Molinari A; Botta M; Saad ST
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):450-461. PubMed ID: 27840303
[TBL] [Abstract][Full Text] [Related]
11. Interaction between Hck and HIV-1 Nef negatively regulates cell surface expression of M-CSF receptor.
Hiyoshi M; Suzu S; Yoshidomi Y; Hassan R; Harada H; Sakashita N; Akari H; Motoyoshi K; Okada S
Blood; 2008 Jan; 111(1):243-50. PubMed ID: 17893228
[TBL] [Abstract][Full Text] [Related]
12. Novel virtual lead identification in the discovery of hematopoietic cell kinase (HCK) inhibitors: application of 3D QSAR and molecular dynamics simulation.
Bavi R; Kumar R; Rampogu S; Kim Y; Kwon YJ; Park SJ; Lee KW
J Recept Signal Transduct Res; 2017 Jun; 37(3):224-238. PubMed ID: 27485399
[TBL] [Abstract][Full Text] [Related]
13. Conserved residues in the HIV-1 Nef hydrophobic pocket are essential for recruitment and activation of the Hck tyrosine kinase.
Choi HJ; Smithgall TE
J Mol Biol; 2004 Nov; 343(5):1255-68. PubMed ID: 15491611
[TBL] [Abstract][Full Text] [Related]
14. A mammalian two-hybrid screening system for inhibitors of interaction between HIV Nef and the cellular tyrosine kinase Hck.
Murakami Y; Fukazawa H; Kobatake T; Yamagoe S; Takebe Y; Tobiume M; Matsuda M; Uehara Y
Antiviral Res; 2002 Jul; 55(1):161-8. PubMed ID: 12076760
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a diaminoquinoxaline benzenesulfonamide antagonist of HIV-1 Nef function using a yeast-based phenotypic screen.
Trible RP; Narute P; Emert-Sedlak LA; Alvarado JJ; Atkins K; Thomas L; Kodama T; Yanamala N; Korotchenko V; Day BW; Thomas G; Smithgall TE
Retrovirology; 2013 Nov; 10():135. PubMed ID: 24229420
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Nef triggers macrophage fusion in a p61Hck- and protease-dependent manner.
Vérollet C; Zhang YM; Le Cabec V; Mazzolini J; Charrière G; Labrousse A; Bouchet J; Medina I; Biessen E; Niedergang F; Bénichou S; Maridonneau-Parini I
J Immunol; 2010 Jun; 184(12):7030-9. PubMed ID: 20488787
[TBL] [Abstract][Full Text] [Related]
17. Re-arrangements of podosome structures are observed when Hck is activated in myeloid cells.
Poincloux R; Vincent C; Labrousse A; Castandet J; Rigo M; Cougoule C; Bordier C; Le Cabec V; Maridonneau-Parini I
Eur J Cell Biol; 2006 Apr; 85(3-4):327-32. PubMed ID: 16546576
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
[TBL] [Abstract][Full Text] [Related]
19. The Src tyrosine kinase Hck is required for Tel-Abl- but not for Tel-Jak2-induced cell transformation.
Pecquet C; Nyga R; Penard-Lacronique V; Smithgall TE; Murakami H; Régnier A; Lassoued K; Gouilleux F
Oncogene; 2007 Mar; 26(11):1577-85. PubMed ID: 16953222
[TBL] [Abstract][Full Text] [Related]
20. Hemopoietic cell kinase (Hck) and p21-activated kinase 2 (PAK2) are involved in the down-regulation of CD1a lipid antigen presentation by HIV-1 Nef in dendritic cells.
Shinya E; Shimizu M; Owaki A; Paoletti S; Mori L; De Libero G; Takahashi H
Virology; 2016 Jan; 487():285-95. PubMed ID: 26584215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
